{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:48:10Z","timestamp":1765820890706,"version":"3.48.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,15]]},"DOI":"10.7759\/cureus.99305","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:44:24Z","timestamp":1765820664000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Effectiveness of Piperacillin-Tazobactam or Fluoroquinolones Versus Third-Generation Cephalosporins in Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Jie Siang","family":"See","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin Yee","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.693652","article-title":"An epidemiological meta-analysis on the worldwide prevalence, resistance, and outcomes of spontaneous bacterial peritonitis in cirrhosis","volume":"8","author":"Tay PW","year":"2021","unstructured":"Tay PW, Xiao J, Tan DJ, et al.. An epidemiological meta-analysis on the worldwide prevalence, resistance, and outcomes of spontaneous bacterial peritonitis in cirrhosis. Front Med (Lausanne). 2021, 8:693652. 10.3389\/fmed.2021.693652","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano S","year":"2019","unstructured":"Piano S, Singh V, Caraceni P, et al.. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology. 2019, 156:1368-80.e10. 10.1053\/j.gastro.2018.12.005","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321790","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"70","author":"Aithal GP","year":"2021","unstructured":"Aithal GP, Palaniyappan N, China L, et al.. Guidelines on the management of ascites in cirrhosis. Gut. 2021, 70:9-29. 10.1136\/gutjnl-2020-321790","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"European Association for the Study of the Liver","year":"2010","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010, 53:397-417. 10.1016\/j.jhep.2010.05.004","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins SW","year":"2021","unstructured":"Biggins SW, Angeli P, Garcia-Tsao G, et al.. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021, 74:1014-48. 10.1002\/hep.31884","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307263.462","article-title":"PTH-016 diagnosis and management of spontaneous bacterial peritonitis: is there a need for an urgent update of national guidelines?","volume":"63","author":"Goel A","year":"2014","unstructured":"Goel A, Murugesan S, Hendrickse MT. PTH-016 diagnosis and management of spontaneous bacterial peritonitis: is there a need for an urgent update of national guidelines?. Gut. 2014, 63:A215. 10.1136\/gutjnl-2014-307263.462","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013120.pub2","article-title":"Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis","volume":"9","author":"Iogna Prat L","year":"2019","unstructured":"Iogna Prat L, Wilson P, Freeman SC, et al.. Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev. 2019, 9:CD013120. 10.1002\/14651858.CD013120.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2023.101484","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad M","year":"2024","unstructured":"Prasad M. Introduction to the GRADE tool for rating certainty in evidence and recommendations. Clin Epidemiol Glob Health. 2024, 25:101484. 10.1016\/j.cegh.2023.101484","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis","volume":"18","author":"Haddaway NR","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev. 2022, 18:e1230. 10.1002\/cl2.1230","journal-title":"Campbell Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002126","article-title":"Response-guided therapy with cefotaxime, ceftriaxone, or ciprofloxacin for spontaneous bacterial peritonitis: a randomized trial: a validation study of 2021 AASLD practice guidance for SBP","volume":"118","author":"Yim HJ","year":"2023","unstructured":"Yim HJ, Kim TH, Suh SJ, et al.. Response-guided therapy with cefotaxime, ceftriaxone, or ciprofloxacin for spontaneous bacterial peritonitis: a randomized trial: a validation study of 2021 AASLD practice guidance for SBP. Am J Gastroenterol. 2023, 118:654-63. 10.14309\/ajg.0000000000002126","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.06.046","article-title":"Empirical treatment with carbapenem versus third-generation cephalosporin for treatment of spontaneous bacterial peritonitis","volume":"19","author":"Kim SW","year":"2021","unstructured":"Kim SW, Yoon JS, Park J, et al.. Empirical treatment with carbapenem versus third-generation cephalosporin for treatment of spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2021, 19:976-86.e5. 10.1016\/j.cgh.2020.06.046","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial","volume":"63","author":"Piano S","year":"2016","unstructured":"Piano S, Fasolato S, Salinas F, et al.. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatology. 2016, 63:1299-309. 10.1002\/hep.27941","journal-title":"Hepatology"},{"key":"ref14","article-title":"Comparison of intravenous ciprofloxacin and ceftriaxone in the management of spontaneous bacterial peritonitis in cirrhosis of the liver at Mayo Hospital, Lahore","volume":"8","author":"Ahmed AC","year":"2014","unstructured":"Ahmed AC, Chaudhary SA, Khan IM. Comparison of intravenous ciprofloxacin and ceftriaxone in the management of spontaneous bacterial peritonitis in cirrhosis of the liver at Mayo Hospital, Lahore. Pak J Med Health Sci. 2014, 8:82-4.","journal-title":"Pak J Med Health Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.645502","article-title":"First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage","volume":"47","author":"Novovic S","year":"2012","unstructured":"Novovic S, Semb S, Olsen H, Moser C, Knudsen JD, Homann C. First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage. Scand J Gastroenterol. 2012, 47:212-16. 10.3109\/00365521.2011.645502","journal-title":"Scand J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02706.x","article-title":"Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost","volume":"23","author":"Angeli P","year":"2006","unstructured":"Angeli P, Guarda S, Fasolato S, et al.. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. Aliment Pharmacol Ther. 2006, 23:75-84. 10.1111\/j.1365-2036.2006.02706.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","article-title":"Comparison of cefotaxime and ofloxacin in the treatment of spontaneous bacterial peritonitis","volume":"15","author":"Taskiran B","year":"2004","unstructured":"Taskiran B, Colakoglu O, Sozmen B, Unsal B, Aslan SL, Buyrac Z. Comparison of cefotaxime and ofloxacin in the treatment of spontaneous bacterial peritonitis. Turk J Gastroenterol. 2004, 15:34-8.","journal-title":"Turk J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(96)70069-0","article-title":"Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis","volume":"111","author":"Navasa MI","year":"1996","unstructured":"Navasa MI, Follo AN, Llovet JM, et al.. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology. 1996, 111:1011-17. 10.1016\/S0016-5085(96)70069-0","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.53685\/jshmdc.v6i1.358","article-title":"Comparative outcomes of piperacillin-tazobactam versus ceftriaxone in managing spontaneous bacterial peritonitis in cirrhotic patients: an observational study","volume":"6","author":"Hussain A","year":"2025","unstructured":"Hussain A, Sheikh MU, Tauseef A, Mohayudin HG, Sadaqat H, Siddiqui WA. Comparative outcomes of piperacillin-tazobactam versus ceftriaxone in managing spontaneous bacterial peritonitis in cirrhotic patients: an observational study. J Shalamar Med Dent Coll. 2025, 6:42-7. 10.53685\/jshmdc.v6i1.358","journal-title":"J Shalamar Med Dent Coll"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/444425-comparative-effectiveness-of-piperacillin-tazobactam-or-fluoroquinolones-versus-third-generation-cephalosporins-in-spontaneous-bacterial-peritonitis-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:44:25Z","timestamp":1765820665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/444425-comparative-effectiveness-of-piperacillin-tazobactam-or-fluoroquinolones-versus-third-generation-cephalosporins-in-spontaneous-bacterial-peritonitis-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.99305","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}